Business Standard

China plans to offer experimental Covid vaccine to students going abroad

The two shots being developed by CNBG -- which are still in the final, third phase of testing -- were authorised for emergency use in China

Coronavirus, vaccine, covid
Premium

CNBG appears to be trying to gauge interest among the general public for its vaccine candidates

Bloomberg
One of China’s leading vaccine developers is working on a plan to inoculate students going overseas with Covid-19 shots that are yet to get regulatory approval, according to people familiar with the matter, as the country pushes scientific boundaries in the race for a viable immunisation.

China National Biotec Group Co., or CNBG, a subsidiary of state-owned Sinopharm Group Co, is in talks with the Chinese government about giving students headed abroad to study its experimental vaccines, said the people, who asked not to be identified as they’re not authorised to speak publicly. Various government agencies are still working on the

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in